CLINICAL_TRIALS
trial_result
· 2021-04-30
Clinical Trial Update: Prednisone Administration in Quiescent COPD Patients to Determine the Effect on Gene Expression [Phase 4]
Summary
Phase 4 trial evaluating prednisone administration in quiescent COPD patients to assess changes in gene expression.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of British Columbia | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: UNKNOWN